Search research articles
Contact Us
Filters
Showing results (51-60 of 1,750) with videos related to
Page
of 175
Sort By:
European Urology
|
October 7, 2020
Reply to Vérane Achard, Alan Dal Pra, and Thomas Zilli's Letter to the Editor re: Carlo A. Bravi, Nicola Fossati, Giorgio Gandaglia, et al. Long-term Outcomes of Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Not as Good as Previously Thought. Eur Urol 2020;78:661-9
Carlo A Bravi, Francesco Montorsi, Alberto Briganti
Oncology (Williston Park, N.Y.)
|
August 22, 2014
Extended lymph node dissection in prostate cancer: a procedure with therapeutic utility
Giorgio Gandaglia, Ettore Di Trapani, Alberto Briganti
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
June 1, 2017
Screening and Treating Prostate Cancer in the Older Patient: Decision Making Across the Clinical Spectrum
Alicia K Morgans, William Dale, Alberto Briganti
European Urology Oncology
|
February 8, 2025
Re: Bertrand F. Tombal, Francisco Gomez-Veiga, Alvaro Gomez-Ferrer, et al. A Phase 2 Randomized Open-label Study of Oral Darolutamide Monotherapy Versus Androgen Deprivation Therapy in Men with Hormone-sensitive Prostate Cancer (EORTC-GUCG 1532). Eur Urol Oncol 2024;7:1051-60
Francesco Montorsi, Giorgio Gandaglia, Francesco Barletta, et al.
Future Oncology (London, England)
|
March 2, 2016
How can we optimize the use of prostate cancer registries?
Giorgio Gandaglia, Nicola Fossati, Francesco Montorsi, et al.
The Journal of Urology
|
July 14, 2023
Long-term Outcomes Following Active Surveillance of Low-grade Prostate Cancer: A Population-based Study Using a Landmark Approach. Letter
Francesco Montorsi, Armando Stabile, Giorgio Gandaglia, et al.
European Urology
|
February 11, 2020
Re: Aurélie De Bruycker, Elise De Bleser, Karel Decaestecker, et al. Nodal Oligorecurrent Prostate Cancer: Anatomic Pattern of Possible Treatment Failure in Relation to Elective Surgical and Radiotherapy Treatment Templates. Eur Urol 2019;75:826-33: Nodal Recurrence of Prostate Cancer in Patients Treated with Radical Intent: Tailoring the Best Salvage Treatment
Francesco Montorsi, Nicola Fossati, Giorgio Gandaglia, et al.
European Urology
|
September 27, 2024
Re: Long-term Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Noninferiority Study Comparing Two Fractionation Schedules in Patients with Low-Risk Prostate Cancer
Giorgio Gandaglia, Francesco Barletta, Alberto Briganti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 17, 2024
Improving Assessment of Radiorecurrent Prostate Cancer: Implications for Salvage Reirradiation
Francesco Montorsi, Mattia Longoni, Alberto Briganti, et al.
European Urology
|
September 10, 2016
Re: Family History and Probability of Prostate Cancer, Differentiated by Risk Category - A Nationwide Population-based Study
Eugenio Ventimiglia, Andrea Salonia, Alberto Briganti, et al.
Page
of 175
Search research articles
Search
Showing results (51-60 of 1,750) with videos related to
Sort By:
Page
of 175
European Urology
|
October 7, 2020
Reply to Vérane Achard, Alan Dal Pra, and Thomas Zilli's Letter to the Editor re: Carlo A. Bravi, Nicola Fossati, Giorgio Gandaglia, et al. Long-term Outcomes of Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Not as Good as Previously Thought. Eur Urol 2020;78:661-9
Carlo A Bravi, Francesco Montorsi, Alberto Briganti
Oncology (Williston Park, N.Y.)
|
August 22, 2014
Extended lymph node dissection in prostate cancer: a procedure with therapeutic utility
Giorgio Gandaglia, Ettore Di Trapani, Alberto Briganti
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
June 1, 2017
Screening and Treating Prostate Cancer in the Older Patient: Decision Making Across the Clinical Spectrum
Alicia K Morgans, William Dale, Alberto Briganti
European Urology Oncology
|
February 8, 2025
Re: Bertrand F. Tombal, Francisco Gomez-Veiga, Alvaro Gomez-Ferrer, et al. A Phase 2 Randomized Open-label Study of Oral Darolutamide Monotherapy Versus Androgen Deprivation Therapy in Men with Hormone-sensitive Prostate Cancer (EORTC-GUCG 1532). Eur Urol Oncol 2024;7:1051-60
Francesco Montorsi, Giorgio Gandaglia, Francesco Barletta, et al.
Future Oncology (London, England)
|
March 2, 2016
How can we optimize the use of prostate cancer registries?
Giorgio Gandaglia, Nicola Fossati, Francesco Montorsi, et al.
The Journal of Urology
|
July 14, 2023
Long-term Outcomes Following Active Surveillance of Low-grade Prostate Cancer: A Population-based Study Using a Landmark Approach. Letter
Francesco Montorsi, Armando Stabile, Giorgio Gandaglia, et al.
European Urology
|
February 11, 2020
Re: Aurélie De Bruycker, Elise De Bleser, Karel Decaestecker, et al. Nodal Oligorecurrent Prostate Cancer: Anatomic Pattern of Possible Treatment Failure in Relation to Elective Surgical and Radiotherapy Treatment Templates. Eur Urol 2019;75:826-33: Nodal Recurrence of Prostate Cancer in Patients Treated with Radical Intent: Tailoring the Best Salvage Treatment
Francesco Montorsi, Nicola Fossati, Giorgio Gandaglia, et al.
European Urology
|
September 27, 2024
Re: Long-term Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Noninferiority Study Comparing Two Fractionation Schedules in Patients with Low-Risk Prostate Cancer
Giorgio Gandaglia, Francesco Barletta, Alberto Briganti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 17, 2024
Improving Assessment of Radiorecurrent Prostate Cancer: Implications for Salvage Reirradiation
Francesco Montorsi, Mattia Longoni, Alberto Briganti, et al.
European Urology
|
September 10, 2016
Re: Family History and Probability of Prostate Cancer, Differentiated by Risk Category - A Nationwide Population-based Study
Eugenio Ventimiglia, Andrea Salonia, Alberto Briganti, et al.
Page
of 175